Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Breast and Gynecologic Cancer Research Group

Programs and Projects

Cervical Cancer Clinical Trials

Ongoing Phase I/II Prevention Trials Funded and Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)

Principal Investigator Funding Mechanism Title of Award Chemopreventive Agent
Mark Einstein, MD
Albert Einstein College of Medicine
R01 Expanded Phase II Trial of Carraguard for Prevention of HPV Infection Carraguard
Francisco Garcia, MD
University of Arizona
PhaseI/II Consortia Contract A Phase II Trial of Polyphenon E for Cervical Cancer
Green Tea Catechins
Brad Monk, MD and Dorothy Wiley, MD
University of California, Irvine
Master Agreement An Exploratory Study to Evaluate the Effect of HPV-16 Vaccine on the Reduction of Viral Load in HPV-16 Positive Women with Persistent Viral Infection, but Low Grade Disease (ASCUS/LSIL)
HSP-E7 Vaccine

** indicates studies that are open to accrual

Back to top